Oncology

A curated roundup of reporting, expert insights, and conversations examining how veterinarians are diagnosing, treating, and rethinking cancer care today.

Do you know what current research says about spay/neuter and its possible link to cancer?

Lead researchers at Penn Vet explain how the samples were handled, what the dogs’ roughly 70% accuracy means for clinicians, and the next steps needed to translate the finding into a clinical test.

The Marion duPont Scott Equine Medical Center is 1 of 2 facilities in the US offering this treatment.

A study reveals promising results for niclosamide stearate in treating canine osteosarcoma, suggesting potential for further clinical trials and improved survival rates.

In a blinded laboratory trial, trained biodetection dogs distinguished serum from dogs with hemangiosarcoma from control samples with about 70% accuracy, supporting the idea that the tumor produces a volatile organic compound signature that might be translated into a future diagnostic.

Christman Chronicles is a monthly, time-saving roundup that links busy veterinarians directly to dvm360’s most important stories and the continuing education that helps keep them current.

Verdinexor tablets (Laverdia; Anivive Lifesciences) are the first oral treatment for managing lymphoma in dogs.

The noninvasive technology from HT VET screens for dermal and subcutaneous masses.

Inflammatory bowel disease (IBD) may progress to feline small cell gastrointestinal (GI) lymphoma, researchers say. Texas A&M University is testing a new treatment option for the cancer.

AAHA’s 2026 oncology guidelines aim to update diagnostics, staging, treatment priorities, and team workflows to help primary care clinics detect, stage, and manage cancer while preserving patient quality of life.

Kidogo, a 13-year-old dachshund, underwent 20 rounds of radiation treatments.

Pamela D. Jones, DVM, DACVIM (Oncology), DACVR (Radiation Oncology), shares strategies for diagnosing and treating canine lymphoma, emphasizing personalized care and emerging therapies.

Multiple approaches to cancer treatment can be initiated by primary care veterinarians.

The system is designed to deliver photon augmented wave stereotactic radiation therapy

OS Therapeutics' veterinary division is developing OST-HER2 for canine osteosarcoma treatment.

In a session at the New York Vet Show, Ann E. Hohenhaus, DVM, DACVIM (Oncology, SAIM), offered a comprehensive list of resources useful to veterinarians with oncology patients.

Akston Biosciences Corporation partnered with Purdue University to develop a drug targeting PD-L1 in dogs with solid tumors.

VolitionRx Limited donated its Nu.Q Vet Cancer Test to support dogs that provide emotional support and comfort to those impacted by crises and disasters.

Female dogs are at a higher risk of developing breast cancer than women.

The survey also found that as the number of lumps seen increased, the likelihood of sampling decreased. Could a “wait-and-see” approach be costing dogs valuable treatment time and compromising outcomes?

The treatment’s success could have important implications for human cancer research.

The pioneering research was launched by the Humanimal Trust, a United Kingdom charity.